GCTK vs LMT · P/E 0.1, $4.1M cap vs P/E 20, rev $20.06B
GlucoTrack Inc (GCTK) versus Lockheed Martin Corporation (LMT) — a side-by-side from cached financials, not a winner call.
GlucoTrack Inc (GCTK) is a medical instruments & supplies company listed on US.
Lockheed Martin Corporation (LMT) is a aerospace & defense company listed on US. It is led by Jim Taiclet.
GCTK does not have a complete income-statement cache yet.
Latest reported LMT revenue for 2026-06-28 was $20.06B. Net income was $1.84B. Revenue was up 11.3% from 2026-03-29 to 2026-06-28. LMT currently screens at market cap $108.37B and trailing P/E 19.9.
GCTK currently screens at market cap $4.1M and trailing P/E 0.1. LMT currently screens at market cap $108.37B and trailing P/E 19.9.
Not investment advice. Open the GCTK and LMT stock pages for the full models.
Not investment advice.